Search Results for "Biosoft Pharma"

07:32 EST 1st March 2015 | BioPortfolio

Matching Channels

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...

Laboratory

Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...

OxyContin

OxyContin, an narcotic analgesic produced by Purdue Pharma LP, nets $3m in sales annually, placing it 8th in the world for annual sales. OxyContin in the brand name for oxycodone, and is similar t...

Eligard

Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormon...

Boehringer Ingelheim

Boehringer Ingelheim is a global pharmaceutical company with annual sales of over $16 billion, making it the 10th largest pharmaceutical company in the world based on sales.  With bases in 47 c...

Matching News

Premier Biosoft – innovative software in life sciences

Premier Biosoft is a biotech company dedicated to accelerating research in life sciences. Premier Biosoft studies the most recent innovations in biology research and translates them into software prod...

Dr. John Wiktorowicz Brings in Rich Experience in Protein Biochemistry as PREMIER Biosoft Expands Its Mass Spectrometry Portfolio

Palo Alto, CA, January 23, 2015 --(PR.com)-- PREMIER Biosoft today announced that eminent protein biochemist, John Wiktorowicz, PhD, has joined the company’s scientific advisory board. “...

VERONA PHARMA PLC - CMO appointment & incorporation of Verona Pharma Inc

Verona Pharma plc ("Verona Pharma" or the "Company") Appointment of Dr Kenneth Newman as Chief Medical Officer and Incorporation of Verona Pharma, Inc. 17 December 2014, Cardiff - Verona Pharma pl...

Omega Pharma rumored to be sought after by big pharma companies

Belgium-based healthcare company Omega Pharma NV is allegedly attracting numerous bids from businesses across the big pharma companies, according to Bloomberg Businessweek. Perrigo and Boehringer Inge...

Celtic Pharma: Attracting Big Pharma with experience and raising US$ 750M

In this interview, filmed at PharmaTelevision’s Oxford Studios, Dr Fintan Walton speaks with Stephen Parker, Partner at Celtic Pharma, a source of private equity and venture capital created in 2004....

Cocrystal Pharma and RFS Pharma Merge to Create Antiviral Development Organization

Cocrystal Pharma, a biotechnology company developing novel antiviral therapeutics for human diseases, today announced the closing of its merger with RFS Pharma, LLC, a privately owned biotech company ...

Cocrystal Pharma and RFS Pharma complete merger

USA-based biotech firm Cocrystal Pharma has announced the closing of its merger with RFS Pharma, a privately owned biotech company founded by renowned drug developer, Raymond Schinazi.

VERONA PHARMA PLC - Half-yearly Report

Verona Pharma plc ("Verona Pharma" or the "Company") Interim results for the six months ended 30 June 2014 Well financed to support further development 11 September 2014, Cardiff - Verona Pharma p...

Matching PubMed Articles

Pharma corruption.

The premium of a big pharma license deal.

Pharma partners with efforts to pool patient genotype and phenotype data.

Pharmaceutical industry, academia and patient advocacy organizations: What is the recipe for synergic (win-win-win) collaborations?

Biological complexity and the need for highly differentiated medicines means that drug discovery and development have become increasingly challenging and expensive. Thus, new paradigms for research an...

Best of Both Worlds: Combining Pharma Data and State of the Art Modeling Technology To Improve in Silico pKa Prediction.

In a unique collaboration between a software company and a pharmaceutical company, we were able to develop a new in silico pKa prediction tool with outstanding prediction quality. An existing pKa pred...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement